Premium
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR HODGKIN LYMPHOMA: A REAL‐LIFE EXPERIENCE BY FONDAZIONE ITALIANA LINFOMI (FIL)
Author(s) -
Massaro F.,
Pavone V.,
Stefani P. M.,
Botto B.,
Pulsoni A.,
Patti C.,
Cantonetti M.,
Visentin A.,
Scalzulli P. R.,
Rossi A.,
Galimberti S.,
Cimminiello M.,
Gini G.,
Musso M.,
Sorio M.,
Arcari A.,
Zilioli V. R.,
Bari A.,
Mannina D.,
Fabbri A.,
Pietrantuono G.,
Annibali O.,
Tafuri A.,
Prete E.,
Mulè A.,
Barbolini E.,
Marcheselli L.,
Luminari S.,
Merli F.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.65_2881
Subject(s) - medicine , brentuximab vedotin , autologous stem cell transplantation , oncology , hematopoietic stem cell transplantation , population , transplantation , surgery , lymphoma , hodgkin lymphoma , environmental health